ACTRN12618001467224已完成未知
Randomised, controlled pilot of the feasibility, acceptability, and efficacy of individualised yoga, compared to group fitness, on symptoms of burnout and traumatic stress in junior doctors.
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Participants must be currently employed as doctors-in-training at RPAH to be eligible.
- •Participants are still eligible with prior yoga experience.
排除标准
- •Participants are excluded with serious cardio-respiratory disorders, including previous cardiac or respiratory failure, angina, and/or chronic dyspnoea.
- •Pregnancy is also excluded.
研究者
相似试验
已完成
1 期
A randomized controlled pilot and feasibility study of multimodal agility-based exercise training versus strength and endurance training to improve Multiple Sclerosis-related fatigue and fatigability during inpatient rehabilitatioG35Multiple sclerosisDRKS00023943eurologisches Rehabilitationszentrum Godeshöhe e.V.22
进行中（未招募）
1 期
A comparison of two human albumin preparations used in the fluid resuscitation of critically ill adults.Hypovolaemia associated with critical illnessMedDRA version: 19.0 Level: PT Classification code 10038749 Term: Resuscitation System Organ Class: 10042613 - Surgical and medical proceduresEUCTR2016-001940-20-GBCentral Manchester University Hospitals NHS Foundation Trust400
已完成
4 期
Evaluation of intravenous fluid resuscitation with either 4% albumin or 20% albumin solution for patients admitted to the intensive care unitow blood volume statesCritical illnessLow blood volume statesCardiovascular - Other cardiovascular diseasesACTRN12615000349549Austin Health400
尚未招募
不适用
Feasibility randomised pilot trial of Havening by zoomAnxietyPost Traumatic Stress DisorderMental Health - AnxietyMental Health - DepressionDepressionACTRN12621001510831Josephine Stanton80
进行中（未招募）
不适用
A pilot, prospective, randomized, open, blinded end point, phase II study of tolerability and efficacy of Eperisone in Amyotrophic Lateral Sclerosis - EPERISONE AND ALSEUCTR2010-020257-13-ITAZIENDA OSPEDALIERO-UNIVERSITARIA